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Abstract 1 
The rise of antibiotic resistant bacterial species is driving the requirement for medical 2 
devices that minimise infection risks. Antimicrobial functionality may be achieved by 3 
modifying the implant design to incorporate a reservoir that locally releases a 4 
therapeutic. For this approach to be successful it is critical that mechanical 5 
functionality of the implant is maintained. This study explores the opportunity to 6 
exploit the design flexibilities possible using additive manufacturing to develop 7 
porous lattices that maximise the volume available for drug loading while maintaining 8 
load-bearing capacity of a hip implant.  9 
Eight unit cell types were initially investigated and a volume fraction of 30% was 10 
identified as the lowest level at which all lattices met the design criteria in ISO 13314. 11 
Finite element analysis (FEA) identified three lattice types that exhibited significantly 12 
lower displacement (10-fold) compared with other designs; Schwartz primitive, 13 
Schwartz primitive pinched and cylinder grid. These lattices were additively 14 
manufactured in Ti-6Al-4V using selective laser melting. Each design exceeded the 15 
minimum strength requirements for orthopaedic hip implants according to ISO 7206-16 
4. The Schwartz primitive (Pinched) lattice geometry, with 10% volume fill and a 17 
cubic unit cell period of 10, allowed the greatest void volume of all lattice designs 18 
whilst meeting the fatigue requirements for use in an orthopaedic implant (ISO 7206-19 
4). This paper demonstrates an example of how additive manufacture may be 20 
exploited to add additional functionality to medical implants.  21 
 22 
Keywords: additive manufacture; drug delivery; finite element analysis; lattice; 23 
mechanical testing; therapeutics  24 
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Introduction  1 
Additive manufacture (AM) is the process of creating a three-dimensional object 2 
through layer-by-layer deposition of material. Commonly used AM techniques to melt 3 
powdered metal material to create near net shape parts are selective laser melting 4 
(SLM) and electron beam melting (EBM). Both of these approaches allow a greater 5 
design flexibility than traditional manufacturing methods to produce metallic parts (1); 6 
however, this advantage is not currently exploited to its full potential in medical 7 
applications. The possibility of new implant designs produced via AM routinely 8 
investigate osseointegration (2). However, increased functionality of implants can 9 
also be created through incorporation and controlled local release of therapeutics 10 
(3), or matching the mechanical properties of implants to the surrounding bone and 11 
tissue, for example through graded structures (4). This improvement in implant 12 
design has been possible due to the advances in additive manufacturing, where 13 
conventional subtractive methods are not capable of achieving such complex 14 
features. 15 
Infection control of implants is a major concern in medicine, due to the increase in 16 
antibiotic resistant species. Recently, Lenguerrand et al. (5) used the National Joint 17 
Registry (NJR) for England, Wales, Northern Ireland and the Isle of Man to 18 
investigate revision surgery due to prosthetic hip joint infection. Between 2005 and 19 
2013, the prevalence of revision surgery due to prosthetic joint infection, within three 20 
months of primary hip arthroplasty, increased 2.3-fold (5). Further, over 1000 21 
procedures are performed due to prosthetic joint infection annually in this NJR region 22 
(5). Incorporating a therapeutic agent into a temporary cement spacer is a common 23 
solution to treat infection as it allows targeted local drug delivery with a controlled 24 
release. When revision surgery is required due to infection of a primary hip 25 
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replacement, 2-stage hip revision is chosen to treat most cases (6, 7). However, a 1 
cement hip spacer can result in poor patient quality of life during its implantation, due 2 
to its limited strength resulting in restricted mobility (8). Thus, an implant that can 3 
withstand normal loading conditions whilst eluting a desired therapeutic would be 4 
advantageous. This may be realised by using AM technologies to create an internal 5 
porous lattice structure to an implant that creates a void volume. A secondary 6 
material loaded with an antibiotic could be incorporated into this void volume, such 7 
as an antibiotic-loaded cement (9), and therapeutics released into the infected 8 
surrounding tissue. It is important to consider the mechanical effect on an implant 9 
when incorporating a lattice into a design, and ensure that fatigue and strength 10 
criteria associated with the implant are still met. 11 
To demonstrate the potential of AM in medical implants, optimisation of an alternate 12 
2-stage hip revision spacer with internal lattice structuring was investigated in this 13 
study, with an example design shown in Figure 1. Titanium alloy (Ti-6Al-4V) was 14 
chosen as the implant material due to its biocompatibility and suitability for 15 
orthopaedic applications (10). SLM was chosen to manufacture lattices due to the 16 
technologies capability to produce small strut diameters of 0.2 mm. It is critical for a 17 
correctly designed implant to withstand deformation, due to induced stress from the 18 
applied physiological loads, and also have a satisfactory fatigue strength. The aim of 19 
this study was to develop and additively manufacture a lattice structure that could be 20 
used in the design of a therapeutically loaded orthopaedic hip implant as an 21 
alternative to a partial-load bearing traditional cement spacer. Ultimately this 22 
approach has the potential to improve patient mobility and as such quality of life, as 23 
well as decrease the need for secondary stage surgery associated with hip revision 24 
due to infection.  25 
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 1 
Figure 1 – Computer Aided Design (CAD) of a hip implant: a) traditional implant; b) increased 2 
functionality due to integration of lattice design, providing a void space to load a therapeutic agent. 3 
 4 
Materials and Methods 5 
Lattice design 6 
Lattices were designed according to ISO 13314 (11), the international standard for 7 
mechanical compression testing of porous metals, briefly explained here. A 8 
cylindrical design with diameter (Do) of 15 mm, and height (Ho) of 15 mm was chosen 9 
for compression lattices, observing the relationship in equation 1 (11). The 10 
association between average pore size (da) and diameter of cylindrical specimen is 11 
specified by equation 2 (11). Notably, the resolution of the M2 Cusing® SLM system 12 
(Concept Laser, Germany) requires a minimum strut diameter of approximately 13 
0.2 mm to achieve an acceptable part quality. Therefore, designs of lattices were 14 
kept within these parameters. 15 
Equation 1 – Specimen height 
 
𝐻𝐻𝑜𝑜 =  𝐷𝐷𝑜𝑜 ~ 2𝐷𝐷𝑜𝑜 
Equation 2 – Specimen diameter 𝐷𝐷𝑜𝑜  ≥ 10 𝑑𝑑𝑎𝑎 
 16 
Compression lattice geometries were created using Simpleware ScanIP software 17 
(Synopsys, Mountain View, USA), for each appropriate unit cell type available 18 
(Figure 2). 2.5D lattices were not considered in this study due to their 19 
inappropriateness for design of AM medical implants. Resampling was set at 0.1 mm 20 
as standard, but was adjusted to 0.2 mm when the number of elements of a 21 
compression lattice exceeded 1 million. Using the Simpleware FE module 22 
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(Synopsys, Mountain View, USA), a coarse mesh was applied to the lattice 1 
geometries and these were exported for finite element analysis (FEA). 2 
To enable incorporation of the largest volume of therapeutic agent, the target volume 3 
fraction (ratio of solid to void) of each cell type was decreased in increments of 10, 4 
until the lowest possible volume fraction was identified whilst maintaining all design 5 
parameters. The unit cell period (the number of cells that fill the image domain along 6 
an axis) was varied in steps of 5. To maintain a cubic structure, the unit cell period 7 
was identical in the X, Y, and Z directions. 8 
As the volume fraction was decreased the strut diameter decreased also, 9 
compensating for the reduction in volume by removing material from the unit cell 10 
shape. Increasing the unit cell period also resulted in a decrease in strut diameter, as 11 
more unit cells were fitted along each axis length of the image domain. Thus, after 12 
determining the lowest volume fraction possible, the highest unit cell period was 13 
designed for each compression lattice. This would present the smallest strut 14 
diameter for each cell type that was within the limits of the SLM machine. 15 
 16 
Figure 2 – CAD compression lattice cylinders (green) at 30%volume fraction, and a cubic unit cell period 17 
of 10 in the X, Y and Z axis. Individual unit cells (blue) with 30% volume fraction. Unit cell type below 18 
each image. Minimum strut and average pore diameters of CAD compression lattices shown for each cell 19 
type, evaluated by Simpleware software. 20 
 21 
Finite element analysis 22 
FEA uses computational methods to simulate applied physical conditions to a 23 
structure, and analyses the theoretical behaviour. In this study, Comsol 24 
Multiphysics® v5.2 (Comsol AB, Stockholm, Sweden) was used to perform FEA. A 25 
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tetrahedral mesh was applied to each lattice geometry (Figure 3). To simulate a 1 
comparable force across all lattices, 2300 N was applied axially, and a fixed restraint 2 
in all directions was applied to the bottom face. The 2300 N relates to the maximum 3 
force applied during fatigue testing of orthopaedic hip implants, as described in ISO 4 
7206-4, the international standard of implants for surgery – partial and total joint 5 
prostheses (12). A stationary study was performed, using material properties for Ti-6 
6Al-4V: Young’s modulus of 113.8 GPa; Poisson’s ratio of 0.342; and density of 7 
4430 kg/m3 (13). The maximum displacement and von Mises stress were used to 8 
evaluate the performance of each design. 9 
Manufacture of parts 10 
Lattice cylinders were fabricated from Ti-6Al-4V gas atomised powder (TLS Technik, 11 
Germany) sized 20-50 µm, with a M2 Cusing® SLM system (Concept Laser, 12 
Germany). Recycled powder was sieved to ensure a powder size <60 µm. 13 
Processing took place under an Argon atmosphere to limit oxygen pickup; the 14 
atmosphere was controlled to <0.1% oxygen. An Nd:YAG laser was used, with a 15 
maximum output power of 400 W, spot size of 60 µm, and wavelength of 1075 nm. 16 
The same optimised process parameters, designed to reduce residual porosity, were 17 
utilised from the authors’ previous study (3). These parameters used an island 18 
scanning strategy with a scanning speed of 1750 mm/s, hatch spacing of 75 µm, 150 19 
W laser power, and 20 µm slice thickness. To improve stability during manufacture, 20 
sacrificial support structures were built between the base substrate and each 21 
individual lattice cylinder, which were removed after manufacture. 22 
Micro-computed tomography 23 
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Lattice cylinders were scanned using a Skyscan1172 micro-computed tomography 1 
(micro-CT) system (Bruker, Belgium) with 80 kV maximum X-ray energy, 8 W beam 2 
power, 1750 ms exposure per projection, aluminium and copper filter, and 3.38 µm 3 
pixel size. MicroCT was only employed on the Schwartz primitive (Pinched) 10% 4 
lattices since reliable results on higher volume fraction lattices was unachievable due 5 
to beam hardening and poor penetration of titanium. Reconstructed data were 6 
visualised in 3D using CTVox software (version 3.0, Bruker). A porosity analysis was 7 
performed using CTAn software (version 1.15.4.0, Bruker). Briefly, a region of 8 
interest was created within the strut material of each lattice, and this was interpolated 9 
across slices of the strut, to create a volume of interest (VOI) of approximately 0.015 10 
mm3. Global thresholding was applied to create a binary image, and a 3D analysis 11 
used to determine the total porosity within the VOI. The mean of 3 values taken from 12 
separate struts was calculated for each sample (n = 5). 13 
Porosity determination using an Archimedes balance 14 
Using an Archimedes balance, the mass of the lattice cylinders was taken in both air 15 
and ethanol, and additionally the height and diameter of each sample was measured 16 
using a Vernier calliper. The density of the lattice material was calculated from 17 
equation 3, where A is the mass of sample in air, B is the mass of sample in ethanol, 18 
ρO is the density of ethanol (0.79 g/cm3), and ρL is the density of air (0.0012 g/cm3). 19 
The apparent solid density (ρC) of the cylinder was calculated from equation 4, where 20 
the volume of the cylinder (V) was calculated from its height and diameter and ρT is 21 
the theoretical density of Ti-6Al-4V (4.43 g/cm3). 22 
Equation 3 – Material density 
𝜌𝜌 =  𝐴𝐴
𝐴𝐴 − 𝐵𝐵
 (𝜌𝜌𝑂𝑂 −  𝜌𝜌𝐿𝐿) +  𝜌𝜌𝐿𝐿 
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Equation 4 – Apparent density 
𝜌𝜌𝐶𝐶 = 𝐴𝐴 𝑉𝑉⁄𝜌𝜌𝑇𝑇  × 100 
 1 
Strut and pore dimensions 2 
The strut and pore dimensions could not be measured with Vernier callipers due to 3 
their geometry within the lattice. Therefore, to validate the manufactured part versus 4 
the stereolithography file (STL) sent for printing, images were taken of the 5 
specimens and the minimum strut and average pore diameters were measured using 6 
ImageJ (National Institutes of Health, Bethesda, MD, USA) (Figure 4). The 7 
photographic images allowed external features to be measured. Three repeat 8 
measurements were taken, and the mean calculated for external minimum strut and 9 
average pore diameters of manufactured lattices, with n = 5 for each lattice unit cell 10 
type. In addition, ImageJ was used to measure average internal strut and pore 11 
diameters for specimens scanned by micro-CT. Five repeat measurements were 12 
taken for strut and pore diameters and the mean calculated, with n = 5 for sample 13 
number. 14 
Mechanical testing  15 
Quasi-static compression tests were undertaken on n = 5 specimens per unit cell 16 
type using a Z030 universal mechanical tester (Zwick/Roell, USA). Testing was 17 
performed according to ISO 13314 (11). Each lattice was compressed at an initial 18 
strain rate of 10-2 s-1 to failure (0.075 mm/s). Failure strain was set to 50% of the 19 
specimen height. However, all specimens failed before the 50% maximum strain limit 20 
or reached the maximum load cell limit of 25 kN. Force and displacement were 21 
measured by the machine and from this, stress-strain curves were plotted for each 22 
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test, where stress and strain were calculated from equation 5 and equation 6, 1 
respectively. Following ISO 13314, results for quasi-elastic gradient (equation 7), 2 
plateau stress between 5-9% strain (Figure 5), first maximum compressive strength 3 
(Figure 5), energy absorption to 10% strain (equation 8) and energy absorption 4 
efficiency (equation 9) were reported (11). If specimens did not fail before the 5 
maximum load of 25 kN, the plateau stress could not be calculated. The plateau end 6 
strain could not be calculated for any of the specimens. 7 
Equation 5 – Compressive stress (N/mm2) 
𝜎𝜎 = 𝐹𝐹
𝐴𝐴
 
Equation 6 – Strain (%) 
𝑒𝑒 =  ∆𝑙𝑙
𝑙𝑙𝑜𝑜
 × 100 
Equation 7 – Quasi elastic gradient (N/mm2) 
 𝐸𝐸𝑞𝑞𝑞𝑞 =  𝜎𝜎𝑒𝑒 
Equation 8 – Energy absorption per unit volume (MJ/m3) 
𝑊𝑊 = 1100 � 𝜎𝜎 𝑑𝑑𝑒𝑒𝑞𝑞00  
Equation 9 – Energy absorption efficiency (%) 
 𝑊𝑊𝑞𝑞 = 𝑊𝑊𝜎𝜎0  ×  𝑒𝑒0  ×  104 
 8 
F is the compressive force and A is the initial cross-sectional surface area 9 
perpendicular to the loading force, in accordance with ISO 13314. Δl is the overall 10 
compressive displacement, and lo is the initial gauge length. e0 is the upper limit of 11 
compressive strain (%) and σ0 is the compressive stress at the upper limit of 12 
compressive strain (N/mm2), and ecr is the initial yield point corresponding to the start 13 
of the plateau regime. 14 
Fatigue testing was performed to emulate the testing standard ISO 7206-4 (12), 15 
which determines the endurance properties of stemmed femoral components, on an 16 
ElectroForce 3300 (Bose Corporation, ElectroForce Systems Group, Minnesota, 17 
10 
 
USA). A sinusoidally varying compressive force between 300 and 2300 N was 1 
applied at 5 Hz until failure or run-out of 5 million cycles (12). The displacement of 2 
lattices was recorded at 300 cycles (f), and as specified in ISO 7206-4 the test was 3 
programmed to end if the specimen displaced greater than either 5 mm or 1.25 × f, 4 
whichever was the greater value. Specimen sample size for fatigue testing was n = 5 
3.  6 
All mechanical testing was performed at room temperature. 7 
Results 8 
Eight standard lattice types available in Simpleware ScanIP (Synopsys, Mountain 9 
View, USA) were chosen for investigation. The lowest common target volume 10 
fraction across all unit cell types, whilst maintaining design parameter requirements, 11 
was 30% (Figure 2). Minimum strut diameter and average pore size were measured 12 
for each CAD (computer aided design) lattice (Figure 2) at 30% target volume 13 
fraction. The designed pore sizes varied from 0.55 mm (Neovius’ surface) to 0.95 14 
mm (Schwartz primitive (Pinched) and Schwartz diamond); and strut diameter varied 15 
from 0.30 mm (Double Schoen gyroid) to 0.60 mm (Cylinder grid). 16 
FEA was performed on the lattices listed in Figure 3 with the von Mises stress and 17 
maximum displacement results displayed. Maximum stresses were noted at the 18 
minimum strut diameters of all lattice designs, and specifically in the vertical struts 19 
for the more cubic orientated lattices (Schwartz primitive, Schwartz primitive 20 
(Pinched) and Cylinder grid). High stresses were also noted due to partially complete 21 
unit cells at the edge of cylinder shapes. The original and displaced lattice cylinder 22 
result from FEA is shown in Figure 3, with a colour map of von Mises stress. The 23 
stiffest cell types identified were the Schwartz primitive, Schwartz primitive 24 
11 
 
(Pinched), and Cylinder grid, which all displaced ≤ 0.02 mm respectively (Figure 3; 1 
identified by *). Therefore, these cell types were chosen for manufacture and 2 
mechanical testing (Figure 4). 3 
 4 
Figure 3 – FEA performed on Schwartz primitive (Pinched) lattice, with 30% volume fraction and a cubic 5 
cell period of 10. Deformation scale increased to 114 with original lattice ghosted, and von Mises stress 6 
displayed as a colour map with scale bar shown. FEA displacement and von Mises stress results for CAD 7 
compression lattices, with cubic unit cell structure of 10 in X, Y and Z axis. 30% volume fraction, except 8 
Schwartz primitive (Pinched) 10%. Number of elements of coarse model mesh at 0.1 mm resampling. If 9 
number of elements exceeded 1 million, models were resampled at 0.2 mm; where this is the case, 10 
lattices are identified with †. The stiffest lattice types chosen for manufacture are highlighted by *. 11 
 12 
The Schwartz primitive (Pinched) lattice was capable of the lowest volume fraction 13 
(10%) whilst maintaining design parameters: Do = 15 mm; Ho = 15 mm; strut 14 
diameter >0.2 mm. Using FEA, this lattice was identified as the strongest unit cell 15 
type at 10% volume fraction, displacing 0.05 mm. Specimens were manufactured for 16 
fatigue testing and porosity analysis with Schwartz primitive (Pinched) unit cell type, 17 
10% volume fraction, and a cubic unit cell period of 10. 18 
 19 
Figure 4 – AM lattices with cubic unit cell period of 10; unit cell type, volume fraction, and designed and 20 
manufactured pore and strut diameters, stated below each lattice. Height (top row) and diameter (bottom 21 
row) of specimens shown (mean ± standard deviation). Minimum strut and average pore diameters 22 
shown below each lattice, analysed with ImageJ. 23 
 24 
Fraction of volume and material 25 
The volume fraction and material density for specimens with the largest volume 26 
available for incorporation of a therapeutic agent were evaluated. Of the 27 
manufactured specimens, the Schwartz primitive (Pinched) lattices at 10% volume 28 
fraction, with unit cell period of 10 in the X, Y and Z axes, contained the highest 29 
12 
 
designed porosity. The level of defects within the manufactured specimens (i.e. 1 
porosity within the lattice struts) calculated by microCT was 99.0 ± 0.7%. The density 2 
of the lattice material was analysed using Archimedes balance measurements, as 3 
4.24 ± 0.11 g/cm3, comparable to the theoretical density of Ti-6Al-4V (4.43 g/cm3). 4 
The volume fraction of the cylinder (designed to be 10%), was calculated from the 5 
Archimedes balance measurements, as 14.18 ± 0.68%. For the Schwartz primitive 6 
(Pinched) 10% lattices scanned by microCT and evaluated by ImageJ, no deviation 7 
was found (variation of 3%) between the designed and manufactured internal strut 8 
and pore diameters (Figure 4). 9 
Mechanical testing 10 
Schwartz primitive and Schwartz primitive (Pinched) 10% compression lattices failed 11 
(reached their first maximum compressive strength) within the quasi-static 12 
compression test limits. Two Schwartz primitive (Pinched) 30% compression lattices 13 
also failed within these test parameters. The remaining (n = 3) Schwartz primitive 14 
(Pinched) 30% lattices, and all the Cylinder grid compression lattices, did not fail 15 
before 25 kN. The first maximum compressive strength could only be calculated for 16 
specimens that failed within the test parameters. However, the stress-strain curves 17 
for each lattice type indicate the Schwartz primitive (Pinched) 30% and Cylinder grid 18 
lattices were plateauing towards the point of failure at 25 kN (Figure 5). 19 
 20 
 21 
Figure 5 – Stress-strain curve for each AM lattice. a) Schwartz primitive 30%; b) Cylinder grid 30%; c) 22 
Schwartz primitive (Pinched) 10%; d) Schwartz primitive (Pinched) 30%. Key: 1) quasi-elastic gradient; 2) 23 
first maximum compressive strength; 3) plateau stress. 24 
  25 
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Table 1 – Mechanical testing results for AM lattices, with 30% volume fraction and cubic unit cell 1 
structure of 10. n = 5, except for † where n = 2. For ‡ energy absorption and efficiency calculated to 5% 2 
strain, otherwise calculated to 10% strain. 3 
Cell type 
Schwartz 
primitive 
30% 
Schwartz 
primitive 
(Pinched) 
30% 
Cylinder grid 
30% 
Schwartz 
primitive 
(Pinched) 
10% 
Plateau stress 
(MPa) --- --- --- 27.8 ± 3.0 
First maximum 
compressive 
strength (MPa) 
126.8 ± 3.8 138.1 ± 0.1†  >140.0 29.7 ± 7.7 
Energy 
absorption 
(kJ/m3) 
5.11 ± 0.37 5.73 ± 0.54 6.43 ± 0.20 0.31 ± 0.04‡ 
Energy 
absorption 
efficiency (%) 
 
45.8 ± 2.6 43.0 ± 2.8 46.0 ± 1.4 2.8 ± 0.4‡ 
Quasi-elastic 
gradient (GPa) 1.93 ± 0.05 2.31 ± 0.04 2.42 ± 0.09 0.92 ± 0.18 
 4 
Fatigue 5 
The Schwartz primitive (Pinched) unit cell with 10% volume fraction and a cubic unit 6 
cell function of 10 was chosen for fatigue testing, due to being the weakest 7 
mechanical structure of the 4 manufactured lattices (Table 1) and containing the 8 
greatest volume void space to incorporate a therapeutic agent. As the weakest 9 
mechanical structure but with the largest volume available for therapeutic 10 
incorporation, if the Schwartz primitive (Pinched) lattice with 10% volume fraction 11 
passed fatigue testing then the stronger lattice types should withstand with fatigue 12 
loading also in theory. Three samples completed 5 million cycles without failure 13 
(Supplementary Figure 1). The samples displaced 0.381 ± 0.115 mm after 300 14 
14 
 
cycles (f), and after 5 million cycles this had increased to 0.393 ± 0.113 mm, thus all 1 
samples passed the fatigue criteria (< 1.25 × f) set in ISO 7206-4. 2 
 3 
Discussion 4 
This paper describes a potential use of lattice design in orthopaedic implants, with 5 
the 2-stage hip replacement spacer identified as a possible selection for redesign 6 
due to its current limited life span and the inability for full patient load bearing. The 7 
results of this study showed that the fatigue life of a Schwartz primitive (Pinched) unit 8 
cell type, with 10% volume fraction and cubic cell function of 10, manufactured in Ti-9 
6Al-4V by SLM, was suitable for use in the design of an orthopaedic hip implant. Use 10 
of such a lattice design would allow for the incorporation of a therapeutic agent, such 11 
as a resorbable antibiotic-loaded cement, to allow the targeted release of a drug. 12 
This could reduce the overall amount of antibiotics required, as the targeted delivery 13 
would allow release of the antibiotics locally rather than if administered by alternative 14 
methods. Whilst the Schwartz primitive (Pinched) 10% lattice design reduces the 15 
mechanical strength of the implant, this study demonstrates that the structure was 16 
capable of meeting the axial load requirements of an orthopaedic hip implant, as 17 
described by ISO 7206-4. A major advantage of this design would be the increased 18 
mobility of a patient during a 2-stage hip revision. There is even the potential to use 19 
the implant as a permanent prosthesis, which is especially beneficial in cases where 20 
further surgery is undesirable, for example in elderly patients (14) or high risk 21 
surgical cases (15). Although this study assessed the capability of designed lattice 22 
structures to meet the axial load conditions of an orthopaedic hip implant, further 23 
work would study the associated torsion and bending forces.  24 
15 
 
A total of 8 reticulated lattice types were designed using CAD, with a possible 1 
common minimum volume fraction of 30%. The Double Schoen gyroid, evaluated by 2 
FEA, was the weakest lattice design (Figure 3; 1.23 GPa von Mises stress), with a 3 
predicted displacement of 0.7 mm; this was approximately ten times weaker than 4 
other lattice designs. Another notably weak lattice was the Neovius’ surface, with von 5 
Mises stress of 1.05 GPa. The common design feature of these cell types is their 6 
organic shape structure, compared to the more cubic design of other cells (Figure 2). 7 
As reported in other studies, stretch dominated structures are generally stiffer than 8 
bending dominated structures, lending themselves as more suitable for weight 9 
efficiency in structural applications (16). Since this study aimed to maximise the void 10 
space available to determine the maximum volume of therapeutic agent that could 11 
be incorporated, stretch dominated structures are an attractive solution to maintain 12 
implant stiffness whilst removing material. This enables targeted drug delivery within 13 
an orthopaedic implant and reduces the amount of antibiotics required to treat an 14 
infection. Further, it provides a long-term implantable for when it is undesirable to 15 
perform secondary surgery to remove a temporary cement spacer. The strongest 16 
lattice types were the Schwartz primitive (Pinched) and Cylinder grid, with von Mises 17 
stresses of 0.17 and 0.15 GPa, respectively (displacing 0.01 mm each). The FEA 18 
results calculated in this study were used to inform the selection of lattice geometry 19 
for AM and subsequently mechanical testing. Future work would involve validating 20 
the FEA model to consider manufacturing defects and the influence of deviation from 21 
the CAD model. 22 
FEA was performed under identical conditions for all lattice types to provide a 23 
comparison between designs. When evaluating lattice designs by FEA, stress 24 
concentrations were noted at the edge of all specimens due to part cubic cells (cells 25 
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that were sectioned to fit within the cylindrical body). As noted in other studies, the 1 
edge effect in FEA models of lattices makes it difficult to accurately model these 2 
geometries (17). The displacement of Schwartz primitive (Pinched) manufactured 3 
lattices (10% volume fraction) during fatigue testing was greater than predicted 4 
during FEA (0.05 mm), due to specimens bedding in. Ultimately, although FEA 5 
influenced the choice of which lattice geometries to manufacture, mechanical testing 6 
of the lattices proved their validity as a choice for orthopaedic hip implants. The 7 
compressive displacement of the Schwartz primitive (Pinched) lattices increased 8 
during fatigue testing by 0.012 mm to 0.393 ± 0.113 mm, thus samples passed the 9 
fatigue criteria (1.25 × f) set in ISO 7206-4. 10 
The density of the printed titanium alloy, calculated within struts as 4.24 ± 0.11 11 
g/cm3, is similar to the theoretical density of Ti-6Al-4V (4.43 g/cm3). This result, 12 
accompanied by the low level of porosity (1.0 ± 0.7%) calculated from microCT data, 13 
confirms minimum defects within the solid material of the structure, even with small 14 
strut diameters of 0.37 mm. 15 
Notably, the accuracy of the manufactured specimens was close to the designed 16 
parts as evidenced by dimensional measurements. Specifically, the average pore 17 
size for Schwartz primitive, Schwartz primitive (Pinched) and Cylinder grid for the 18 
designed and manufactured parts were similar; 6%; -2%; -3%; variation from design 19 
respectively. Furthermore, the minimum strut diameters for the same cell types 20 
measured from the manufactured parts exhibited 29%, -4% and 6% variation from 21 
design respectively. Similarly, the designed strut and pore diameters of Schwartz 22 
primitive (Pinched) 10% lattices were designed as 0.29 mm and 1.18 mm. The 23 
external strut and pore diameters measured by photography and ImageJ varied by 24 
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28% and -3%, while the internal diameters (0.30 ± 0.03 mm and 1.22 ± 0.03 mm) 1 
measured by microCT and ImageJ varied by 3% and 3%. Although the greatest 2 
variability of strut diameter may appear high at 29% (Schwartz primitive (Pinched)), it 3 
is worth noting that the standard deviation of measurements for the minimum struts 4 
manufactured diameter deviated a maximum of 0.17 mm from the designed 5 
geometry, and the average pore size a maximum of 0.11 mm. These values are 6 
beyond the resolution of the SLM machine used (0.2 mm), and therefore it can be 7 
assumed that the predominant cause of measurement variation is most likely due to 8 
the triangulation process when creating an STL file.  9 
Traditionally, AM implants are finished through polishing techniques, therefore, 10 
further investigation to assess the challenges associated with finishing lattice 11 
structures would be beneficial. Although the example in this paper has investigated 12 
the potential of lattices in the design of orthopaedic hip spacers, another use of 13 
lattices is to mechanically match an implant to surrounding tissue (18). Titanium 14 
alloys are the traditional material of choice for manufacture of implants due to their 15 
biocompatibility, corrosion resistance and mechanical properties (10, 19, 20). 16 
However, stress shielding is commonly cited as a barrier to titanium implants (19, 21, 17 
22), since the material is significantly stiffer than that of the surrounding bone. The 18 
elastic modulus of cortical and cancellous bone varies from 3 to 30 GPa and 0.02 to 19 
0.3 GPa, respectively (23, 24), whereas the elastic modulus of Ti-6Al-4V is 20 
significantly greater at 113 GPa (13). It is hypothesised that a lower Young’s 21 
modulus for the implant material results in more deformation of the implant and 22 
therefore better bone ingrowth (25). A study by Schouman showed that by reducing 23 
the overall stiffness of an implant through increased porosity, resulted in better bone 24 
formation compared to a rigid design (21). By mechanically matching an implant to 25 
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surrounding bone, it is possible to prevent stress shielding and promote improved 1 
osseointegration. The results of this study found that the quasi-elastic modulus of the 2 
investigated lattices ranged from 0.92 ± 0.18 to 2.42 ± 0.09 MPa. These results are 3 
within the range of those presented elsewhere: 2-6 GPa, with strut and pore 4 
diameters of 400 µm and 650 µm, and relative density of 0.3 (26); and 0.5-1.5 GPa, 5 
with 0.4 mm and 0.6 mm strut and pore diameter, and relative density 14% (27). 6 
Notably, the results of this study are similar to the lower elastic modulus range of 7 
cortical bone. Assuming a solid titanium structure would have an elastic modulus of 8 
113 GPa, by varying the lattice geometry through an increase in volume fraction it is 9 
predicted the modulus of the lattice structures could be designed to match the 10 
variation in cortical bone. The manufactured specimens within this study failed at, or 11 
around, a strain of 0.1 due to vertical struts within a layer fracturing. This strain range 12 
is similar to that achieved in other studies (26). As vertical struts fractured at high 13 
loads, the machine experienced rapid unloading (evident in Figure 5a), and therefore 14 
tests were automatically stopped at this point due to the machine safety mechanism. 15 
These lattices, therefore, did not reach the plateau stage. The exception to this is the 16 
Schwartz primitive (Pinched) 10% lattice, which failed before a strain of 0.1 but at a 17 
much lower load (Figure 5c), therefore plateau strength could be calculated for this 18 
lattice type (Table 1). 19 
Although this study demonstrates the suitability of lattice geometries for use in load 20 
bearing orthopaedic applications, their design was limited to cylindrical geometry 21 
with constant cross-sectional area to comply with ISO 13314. The final geometry of 22 
lattices is still to be determined. Future work would involve further testing to evaluate 23 
the effect of cross sectional area over which the lattice was applied. A similar 24 
approach could be adopted to this study, which iterates between FEA and 25 
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experimental analysis, to assess the design envelope in which this lattice could be 1 
employed. 2 
The use of AM is not currently being exploited to its full potential in medical devices. 3 
This study assesses the potential of a lattice design as an alternative for a cement 4 
hip spacer, notably this approach could add value to other orthopaedic cases. 5 
Implementation could decrease complications such as stress shielding by matching 6 
implant strength to patient-specific bone properties, or to allow targeted delivery of 7 
drugs by incorporating a chamber within an implant whilst maintaining associated 8 
strength and fatigue requirements.  9 
Conclusions 10 
The design of implants can be redefined to increase functionality due to advances in 11 
additive manufacture, with orthopaedic implants no longer restricted to simply 12 
mechanically replacing or supporting damaged joints and bones. Here, we explore 13 
the potential to exploit the void volume of porous lattice structures as a reservoir for 14 
a secondary material containing a therapeutic agent. There is also the potential to 15 
design implants containing lattice structures to mechanically match surrounding bone 16 
and reduce stress shielding. This study assessed the suitability of additively 17 
manufactured titanium lattices as an alternative design for hip cement spacers, to 18 
decrease associated morbidity and further surgery. The weakest lattice design 19 
(Schwartz primitive (Pinched) 10%), with the greatest volume void, withstood 5 20 
million cycles of loading between 300 and 2300 N. In summary, this study confirms 21 
that AM methods can produce a lattice design for use in a titanium implant that could 22 
allow targeted drug delivery of a loaded therapeutic, without compromising the 23 
fatigue life of a load bearing orthopaedic hip implant.  24 
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Supplementary information 1 
 2 
Supplementary Figure 1: Fatigue test data to 5 million cycles for Schwartz primitive (Pinched) unit cell 3 
with 10% volume fraction and a cubic unit cell function of 10. Applied peak and trough load over 5 million 4 
cycles (a). Strain (%) versus number of cycles for specimen 1 (b), specimen 2 (c), and specimen 3 (d).  5 
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